The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ECOG-ACRIN EAA172: Phase 1/2 study of daratumumab, bortezomib, dexamethasone (DVd) with or without venetoclax in relapsed/refractory multiple myeloma (RRMM) with assessment for t(11;14) status.
 
Michael A. Thompson
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - AIM Specialty Health; Celgene; GlaxoSmithKline; Strata Oncology; Syapse; Takeda; VIA Oncology
Patents, Royalties, Other Intellectual Property - UpToDate, Peer Review for Plasma Cell Dyscrasias (Editor: Robert Kyle)
Travel, Accommodations, Expenses - GlaxoSmithKline; Syapse; Takeda
Other Relationship - Doximity
 
Susanna J. Jacobus
No Relationships to Disclose
 
Shaji Kumar
Honoraria - Dr. Reddy's
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Adaptive Biotechnologies; Amgen (Inst); Celgene (Inst); Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
 
Murali Janakiram
Consulting or Advisory Role - miRagen; Seagen
 
Sagar Lonial
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Juno Therapeutics; Merck; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
 
Matthias Weiss
No Relationships to Disclose
 
Natalie Scott Callander
No Relationships to Disclose
 
S. Vincent Rajkumar
Patents, Royalties, Other Intellectual Property - Authorship Royalties from Up To Date